Recent clinical data further support this effect: perindopril therapy in essential hypertensive patients was shown to reduce adrenaline-induced platelet aggregation over one month of treatment, suggesting ACE inhibitors can enhance NO-mediated anti-aggregatory function in vivo. Here, ACE is linked to essential hypertension.